Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease

被引:3
|
作者
Mitchell, Jonathan [1 ]
Herrick-Reynolds, Kayleigh [2 ]
Motter, Jennifer D. [1 ]
Teles, Mayan [1 ]
Kates, Olivia [3 ]
Sung, Hannah [1 ]
Chen, Po-Hung [3 ]
King, Elizabeth [1 ]
Cameron, Andrew [1 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Surg, 720 Rutland Ave, Ross 765, Baltimore, MD 21205 USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 09期
基金
美国国家卫生研究院;
关键词
FOLLOW-UP; PREDICTORS; ABSTINENCE; RELAPSE;
D O I
10.1097/TXD.0000000000001532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT. Methods. A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email. Results. Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."Conclusions. More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Transplant Center Attitudes Towards Early Liver Transplantation for Alcohol-associated Liver Disease
    Mitchell, Jonathan
    Motter, Jennifer
    Teles, Mayan
    Herrick-Reynolds, Kayleigh
    Sung, Hannah
    Chen, Po-Hung
    King, Elizabeth
    Cameron, Andrew
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S58 - S58
  • [2] Liver Transplant for Alcohol-Associated Liver Disease
    Zhang, Bo-Han
    Cai, Yun-Shi
    Yang, Jia-Yin
    [J]. JAMA SURGERY, 2022, 157 (04) : 360 - 360
  • [3] Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease
    Herrick-Reynolds, Kayleigh M.
    Punchhi, Gopika
    Greenberg, Ross S.
    Strauss, Alexandra T.
    Boyarsky, Brian J.
    Weeks-Groh, Sharon R.
    Krach, Michelle R.
    Anders, Robert A.
    Gurakar, Ahmet
    Chen, Po-Hung
    Segev, Dorry L.
    King, Elizabeth A.
    Philosophe, Benjamin
    Ottman, Shane E.
    Wesson, Russell N.
    Garonzik-Wang, Jacqueline M.
    Cameron, Andrew M.
    [J]. JAMA SURGERY, 2021, 156 (11) : 1026 - 1034
  • [4] Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease
    Lee, Brian P.
    Vittinghoff, Eric
    Pletcher, Mark J.
    Dodge, Jennifer L.
    Terrault, Norah A.
    [J]. HEPATOLOGY, 2020, 72 (01) : 130 - 139
  • [5] Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis
    Schroeder, Matthew
    Pedersen, Mark
    Petrasek, Jan
    Grant, Lafaine
    [J]. HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
  • [6] Patient reflections, challenges, and supports related to early liver transplant for severe alcohol-associated liver disease
    Chen, Po-Hung
    Sung, Hannah C.
    Punchhi, Gopika
    Krach, Michelle
    Greenberg, Ross
    Gianaris, Kevin
    Teles, Mayan
    Kaplow, Katya
    Wheatley, Jason
    Cameron, Andrew M.
    Chander, Geetanjali
    [J]. LIVER TRANSPLANTATION, 2023, 29 (07) : 745 - 756
  • [7] Early Liver Transplant for Alcohol-associated Liver Disease Has Excellent Survival but Higher Rates of Harmful Alcohol Use
    Musto, Jessica A.
    Palmer, Geralyn
    Nemer, Mary
    Schell, Trevor
    Waclawik, Gabrielle
    Glover, Quarshie
    Lucey, Michael R.
    Osman, Fay
    Rice, John P.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (08)
  • [8] The Experience of the Alcohol-Associated Liver Disease Organ Transplant Recipient Following Liver Transplantation
    Greenberg, Cindy
    Roush, Karen
    [J]. NURSING RESEARCH, 2024, 73 (03) : E117 - E117
  • [9] Harm reduction approach: An ethical proposal for liver transplant recipients with alcohol-associated liver disease
    Kim, Sue Hyon
    Serper, Marina
    [J]. TRANSPLANTATION, 2024, 108 (09) : 321 - 322
  • [10] Alcohol-associated liver disease predicts increased post-liver transplant opioid use
    Johnson-Laghi, Krystina A.
    Woo, Stephanie M.
    Zafar, Zaeema
    Fernandez, Stephen
    Desale, Sameer
    Robertazzi, Suzanne E.
    Smith, Coleman, I
    Thomas, Arul M.
    Lalos, Alexander T.
    Georgia, Sarah J.
    Jenkins, Michelle L.
    Faust, Thomas W.
    Fishbein, Thomas M.
    Satoskar, Rohit S.
    Rangnekar, Amol S.
    Hsu, Christine C.
    [J]. CLINICAL TRANSPLANTATION, 2022, 36 (12)